Related Experiment Video

Updated: May 6, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

563

Emerging role of microRNAs in cancer and cancer stem cells

Jin Hao1, Sen Zhao, Yueling Zhang

  • 1Department of Orthodontics, State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, West China School of Stomatology, Sichuan University, Chengdu, 610041, China.

Journal of Cellular Biochemistry
|October 30, 2013
PubMed

Insights

Cancer stem cells (CSCs) drive tumor formation and metastasis. A new study reveals how microRNAs (miRNAs) regulate CSCs through antagonistic crosstalk, offering therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cancer stem cells (CSCs) are crucial for tumor initiation, metastasis, and recurrence.
  • The molecular mechanisms governing CSC generation and regulation remain largely unknown.
  • MicroRNAs (miRNAs) are increasingly recognized for their roles in cancer development and CSC function.

Purpose of the Study:

  • To review the current understanding of miRNA-mediated regulation in cancer and CSCs.
  • To elucidate the novel mechanism of antagonistic miRNA crosstalk in CSC regulation.
  • To discuss the therapeutic potential of targeting CSCs via miRNA modulation.

Main Methods:

  • Literature review of recent studies on miRNAs, CSCs, and cancer therapeutics.
  • Analysis of molecular mechanisms underlying miRNA-miRNA interactions.
  • Discussion of preclinical and clinical implications of targeting CSCs.

Main Results:

  • CSCs, a small cell fraction, are key drivers of tumor formation and metastasis.
  • miRNAs play a significant role in cancer progression and CSC functionality.
  • A novel mechanism of antagonistic miRNA crosstalk regulating CSCs has been identified.

Conclusions:

  • miRNA dysregulation is implicated in cancer and CSC development.
  • Antagonistic miRNA crosstalk represents a critical regulatory pathway for CSCs.
  • Targeting CSCs through miRNA manipulation holds promise for cancer therapy.
Keywords:
CANCERCANCER STEM CELLSCANCER THERAPYMicroRNAMicroRNA-ANTAGONISM

More Related Videos

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

8.1K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

6.8K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
MicroRNAs01:22

MicroRNAs

9.8K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.3K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

2.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K